Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?

Autores
Christopoulou, Ioanna; Roose, Kenny; Ibañez, Lorena Itatí; Saelens, Xavier
Año de publicación
2014
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Influenza A virus is a pathogen that is feared for its capacity to cause pandemics. In this review, we illustrate the clinical evidence which support the theory that bacterial co-infection is a considerable risk factor for exacerbated disease during pandemic and seasonal influenza, including infection with influenza B viruses. We provide an overview of the multiple and diverse mechanisms that help explain how influenza creates an opportunity for replication of secondary bacterial infections. Influenza vaccines and pneumococcal vaccines are widely used and often in overlapping target groups. We summarize the evidence for a protective effect of influenza immunization against bacterial infections, and vice versa of pneumococcal vaccines against influenza-associated pneumonia and lethality. It is important that future implementation of broadly protective influenza vaccines also takes into account protection against secondary bacterial infection.
Fil: Christopoulou, Ioanna. University of Ghent; Bélgica
Fil: Roose, Kenny. University of Ghent; Bélgica
Fil: Ibañez, Lorena Itatí. University of Ghent; Bélgica. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencia y Tecnología "Dr. César Milstein". Fundación Pablo Cassará. Instituto de Ciencia y Tecnología ; Argentina
Fil: Saelens, Xavier. University of Ghent; Bélgica
Materia
Influenza Virus
Pandemic
S. Pneumoniae
Secondary Bacterial Infection
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/40343
Acceder
id CONICETDig_c0012022df8e1af1c18e1b8fad9f9399
oai_identifier_str oai:ri.conicet.gov.ar:11336/40343
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?Christopoulou, IoannaRoose, KennyIbañez, Lorena ItatíSaelens, XavierInfluenza VirusPandemicS. PneumoniaeSecondary Bacterial Infectionhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Influenza A virus is a pathogen that is feared for its capacity to cause pandemics. In this review, we illustrate the clinical evidence which support the theory that bacterial co-infection is a considerable risk factor for exacerbated disease during pandemic and seasonal influenza, including infection with influenza B viruses. We provide an overview of the multiple and diverse mechanisms that help explain how influenza creates an opportunity for replication of secondary bacterial infections. Influenza vaccines and pneumococcal vaccines are widely used and often in overlapping target groups. We summarize the evidence for a protective effect of influenza immunization against bacterial infections, and vice versa of pneumococcal vaccines against influenza-associated pneumonia and lethality. It is important that future implementation of broadly protective influenza vaccines also takes into account protection against secondary bacterial infection.Fil: Christopoulou, Ioanna. University of Ghent; BélgicaFil: Roose, Kenny. University of Ghent; BélgicaFil: Ibañez, Lorena Itatí. University of Ghent; Bélgica. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencia y Tecnología "Dr. César Milstein". Fundación Pablo Cassará. Instituto de Ciencia y Tecnología ; ArgentinaFil: Saelens, Xavier. University of Ghent; BélgicaTaylor & Francis2014-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/40343Christopoulou, Ioanna; Roose, Kenny; Ibañez, Lorena Itatí; Saelens, Xavier; Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?; Taylor & Francis; Expert Review Of Vaccines; 14; 1; 1-2014; 55-671476-0584CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1586/14760584.2015.957191info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/abs/10.1586/14760584.2015.957191info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T11:26:00Zoai:ri.conicet.gov.ar:11336/40343instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 11:26:00.66CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
title Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
spellingShingle Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
Christopoulou, Ioanna
Influenza Virus
Pandemic
S. Pneumoniae
Secondary Bacterial Infection
title_short Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
title_full Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
title_fullStr Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
title_full_unstemmed Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
title_sort Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?
dc.creator.none.fl_str_mv Christopoulou, Ioanna
Roose, Kenny
Ibañez, Lorena Itatí
Saelens, Xavier
author Christopoulou, Ioanna
author_facet Christopoulou, Ioanna
Roose, Kenny
Ibañez, Lorena Itatí
Saelens, Xavier
author_role author
author2 Roose, Kenny
Ibañez, Lorena Itatí
Saelens, Xavier
author2_role author
author
author
dc.subject.none.fl_str_mv Influenza Virus
Pandemic
S. Pneumoniae
Secondary Bacterial Infection
topic Influenza Virus
Pandemic
S. Pneumoniae
Secondary Bacterial Infection
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Influenza A virus is a pathogen that is feared for its capacity to cause pandemics. In this review, we illustrate the clinical evidence which support the theory that bacterial co-infection is a considerable risk factor for exacerbated disease during pandemic and seasonal influenza, including infection with influenza B viruses. We provide an overview of the multiple and diverse mechanisms that help explain how influenza creates an opportunity for replication of secondary bacterial infections. Influenza vaccines and pneumococcal vaccines are widely used and often in overlapping target groups. We summarize the evidence for a protective effect of influenza immunization against bacterial infections, and vice versa of pneumococcal vaccines against influenza-associated pneumonia and lethality. It is important that future implementation of broadly protective influenza vaccines also takes into account protection against secondary bacterial infection.
Fil: Christopoulou, Ioanna. University of Ghent; Bélgica
Fil: Roose, Kenny. University of Ghent; Bélgica
Fil: Ibañez, Lorena Itatí. University of Ghent; Bélgica. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencia y Tecnología "Dr. César Milstein". Fundación Pablo Cassará. Instituto de Ciencia y Tecnología ; Argentina
Fil: Saelens, Xavier. University of Ghent; Bélgica
description Influenza A virus is a pathogen that is feared for its capacity to cause pandemics. In this review, we illustrate the clinical evidence which support the theory that bacterial co-infection is a considerable risk factor for exacerbated disease during pandemic and seasonal influenza, including infection with influenza B viruses. We provide an overview of the multiple and diverse mechanisms that help explain how influenza creates an opportunity for replication of secondary bacterial infections. Influenza vaccines and pneumococcal vaccines are widely used and often in overlapping target groups. We summarize the evidence for a protective effect of influenza immunization against bacterial infections, and vice versa of pneumococcal vaccines against influenza-associated pneumonia and lethality. It is important that future implementation of broadly protective influenza vaccines also takes into account protection against secondary bacterial infection.
publishDate 2014
dc.date.none.fl_str_mv 2014-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/40343
Christopoulou, Ioanna; Roose, Kenny; Ibañez, Lorena Itatí; Saelens, Xavier; Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?; Taylor & Francis; Expert Review Of Vaccines; 14; 1; 1-2014; 55-67
1476-0584
CONICET Digital
CONICET
url http://hdl.handle.net/11336/40343
identifier_str_mv Christopoulou, Ioanna; Roose, Kenny; Ibañez, Lorena Itatí; Saelens, Xavier; Influenza vaccines to control influenza-associated bacterial infection: Where do we stand?; Taylor & Francis; Expert Review Of Vaccines; 14; 1; 1-2014; 55-67
1476-0584
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1586/14760584.2015.957191
info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/abs/10.1586/14760584.2015.957191
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis
publisher.none.fl_str_mv Taylor & Francis
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846781814701555712
score 12.982451

Publicaciones similares